Emmessar Biotech & Nutrition Ltd. - Quarterly/Annual Result Disclosures and Notes dated 31 Dec 2018
Auditor and Management Disclosures and Notes for the quarterly results dated 31 Dec 2018
1. The above financial results have been prepared in accordance with Indian Accounting Standards (IND-AS-34 "Interim Financial Reporting") as prescribed under Section 133 of the Comapnies Act, 2013 read with Rule 3 of the Companies (Indian Accounting Standards) Rules, 2015 and the Companies (Indian Accounting Standards) Amendment Rules, 2016 as amended therafter.
2. The above financial results were taken on record by the Board of Directors and the the Audit Committee at their meeting held on 2nd Feb 2019 and have been subjected to Limited Review by the Statutory Auditors.
3. The limited review as required under Regulations 33 of the SEBI (Listing obligation and disclosure requirements) Regulations 2015 has been completed by the Auditors of the Company.
4. The Company operates two segments ie. Healthcare and Rent on leasehold land during this quarter.
5. The Government of India has implemented Goods and Services Tax (GST) w.e.f 1st July 2017 which replaces excise duty and various other indirect taxes. As per Ind AS, sales for the quarter and nine months ended 31st Dec 2018, quarter ended 30th Sept 2018, June 2018, December 2017 and Sept 2017 are reported net of GST. The year ended 31st Mar-2018 and six monthes ended 30th Sept 2017 includes excise duty upto June 2017.
6. Deferred tax and provision for taxation will be calculated annually.
7. One investor compliant was received and the same was disposed off during the quarter ended 31st Dec 2018.